Publication | Closed Access

Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study

Surgical OncologyPancreatic CancerMedicineImmunologyImmune Checkpoint InhibitorCancer TreatmentPhase 2ImmunotherapyOncologyRadiation OncologyAlgenpantucel-l Immunotherapy